Clinical course of patients with cisplatin (CDDP)-associated neuropathy compared to other neurotoxic chemotherapy.

Costantine Albany,Travis J. Dockter,Eric Wolfe,Deirdre R. Pachman,Nina D. Wagner-Johnston,Kayla Marie Lazzara,Lina M Sego,Sara I Edwards,Christin I Snow,Nasser H. Hanna,Lawrence H. Einhorn,Charles L. Loprinzi,Brian A. Costello

Clinical course of patients with cisplatin (CDDP)-associated neuropathy compared to other neurotoxic chemotherapy.

2019

Costantine Albany
Travis J. Dockter
Eric Wolfe
Deirdre R. Pachman
Nina D. Wagner-Johnston
Kayla Marie Lazzara
Lina M Sego
Sara I Edwards
Christin I Snow
Nasser H. Hanna
Lawrence H. Einhorn
Charles L. Loprinzi
Brian A. Costello

e23078Background: There are limited patient (pt) reported outcome data regarding CDDP neurotoxicity. Methods: CDDP-induced peripheral neuropathy was evaluated in pts with testicular cancer planning...

Keywords:

Oncology
Pathology
Cisplatin
Internal medicine
Chemotherapy
Medicine
Peripheral neuropathy
Neurotoxicity
clinical course
outcome data
Testicular cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations